Synthesis of Oligonucleotides Containing a Dna Distorting Interstrand Crosslink Produced by Mitomycins

Area of Science:

• Molecular Biology
• Medicinal Chemistry
• Biochemistry

Background:

• Mitomycin C (MC) is a chemotherapy drug that inhibits cancer cell growth by forming DNA interstrand crosslinks (ICLs).
• MC-induced ICLs minimally distort the DNA backbone, preserving B-DNA structure.
• Cellular machinery may repair ICLs differently based on their structural impact.

Purpose of the Study:

• To synthesize a novel mitomycin ICL derivative that causes significant DNA distortion and minor groove widening.
• To create and characterize DNA substrates with defined monoadducts or ICLs of this new derivative.
• To investigate how DNA distortion influences the cytotoxic effects of mitomycin-induced ICLs.

Main Methods:

• Synthesis of novel mitomycin ICL-containing oligonucleotides.
• Characterization using enzymatic digestion, mass spectrometry, circular dichroism, and thermal denaturation.
• Molecular Dynamics simulations to compare structural distortions.

Main Results:

• Successful synthesis of oligonucleotides with a novel, DNA-distorting mitomycin ICL.
• Detailed characterization of the structural and biophysical properties of these modified oligonucleotides.
• Comparative structural analysis of the novel ICL against less-distorting MC ICLs via simulations.

Conclusions:

• The novel mitomycin ICL provides a new tool for studying DNA damage and repair mechanisms.
• Significant DNA distortion by ICLs may represent a distinct class of DNA damage.
• This research facilitates a deeper understanding of structure-activity relationships in DNA crosslinking agents.